S.L.S – Cell Cure Technologies is a private limited company incorporated under the Companies act,1956, Govt. of India, by a group of highly qualified and experienced professionals. The company has established a state of the art R&D laboratory and offering Biotech based In-vitro Molecular Diagnostic testing, predictive diagnostics for life style based and other diseases. The predictive diagnostics is focused on preserving wellness and also at diagnosing illness. The molecular testing would be based on modern methods like PCR, RT-PCR, and Microarray etc. These techniques would also be employed to detect food borne pathogens.
9. Dr.Shivraj Dasari
Molecular Diagnostics is Transforming Medicine
Pre-natal testing
Disease predisposition
Disease detection
Drug selection
Recurrence monitoring
Key questions
Need for Molecular tests
“Is the baby
healthy? “
“Which diseases
are this patient at
risk for?”
“Does this
patient have
disease?”
“What drugs
should I
prescribe?”
“How the
disease
relapsed?”
Molecular
diagnostics is
>$5 billion
market WW and
growing at
>24% annually
10. Dr.Shivraj Dasari
Molecular Diagnostics
•PCR based screening
For viral, bacterial,
fungal pathogens
•qPCR for Viral loads
•Food pathogens
A
Infectious disease
screening
•Patients are different
•Medicines are not
differentiated
•Health risk analysis:
•Monitoring of therapy
•Identification of drug
resistence
•Target validation molecule
becomesTherapeutic molecule
C
Pharmaco-genomics
•Platform based
technologies
•Microarray based
•Genetic screening
•Life style diseases
•Cancer panel
•STD panel
•Familial Hyper
•cholestremia
B
Predictive
diagnostics
12. Dr.Shivraj Dasari
WHAT WE DO?
R & D
• Catalogue , identify disease-associated genetic
markers and validate them.
Testing
• Assess an individual’s disease risk according to the
validated single or a group of genetic markers.
Services
• Provide personalized disease prevention
strategies.